GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
73 hedge funds and large institutions have $479M invested in GenMark Diagnostics, Inc in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 12 reducing their positions, and 14 closing their positions.
217% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 12
68% more capital invested
Capital invested by funds: $285M → $479M (+$195M)
11.06% more ownership
Funds ownership: 84.04% → 95.1% (+11%)
0% more funds holding
Funds holding: 73 → 73 (0)
0% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 14
77% less call options, than puts
Call options by funds: $6K | Put options by funds: $26K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$33.2M |
| 2 |
JP Morgan Chase
New York
|
+$18.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.2M |
| 4 |
VAM
Visium Asset Management
New York
|
+$8.37M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$7.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$6.45M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$2.33M |
| 3 |
D.E. Shaw & Co
New York
|
-$1.22M |
| 4 |
GI
GLG Inc
New York
|
-$1.14M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.11M |
GNMK Hedge Fund Activity: Q3 2013 in Review
73 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2013, worth a combined $479M — up 68% from $285M a quarter earlier.
Fund positioning in GNMK was balanced in Q3 2013: 14 funds opened new positions, 14 closed out, 38 added to existing stakes and 12 trimmed.
The largest buyer was Putnam Investments, adding an estimated $33.2M. The largest seller was BlackRock Advisors, cutting an estimated $6.45M.
- 73 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2013, unchanged from Q2 2013.
- Funds reported $479M of GenMark Diagnostics, Inc stock for Q3 2013, up 68% quarter-over-quarter.
- 14 funds opened new GenMark Diagnostics, Inc positions in Q3 2013 and 14 closed out, a net change of 0 holders.
- The largest GenMark Diagnostics, Inc buyer in Q3 2013 was Putnam Investments, an estimated $33.2M added.
- The largest GenMark Diagnostics, Inc seller in Q3 2013 was BlackRock Advisors, an estimated $6.45M sold.
Based on aggregated 13F filings for Q3 2013.